⌘K

Login Start Free

Home/Filings/4/0001437749-24-035771

4//SEC Filing

Pittman Scott M. 4

Accession 0001437749-24-035771

CIK 0001091596other

View on SEC.gov Company Profile

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 5:51 PM ET

Size

13.3 KB

Accession

0001437749-24-035771

Insider Transaction Report

Form 4

Period: 2024-11-15

Nuo Therapeutics, Inc.AURX

Pittman Scott M.

Director10% Owner

Transactions

Exercise/Conversion
Option to Purchase Common Stock
2018-08-09−121,875→ 0 total
Exercise: $0.40From: 2018-08-09Exp: 2025-08-09→ Common Stock (121,875 underlying)
Exercise/Conversion
Option to Purchase Common Stock
2018-12-31−62,500→ 0 total
Exercise: $0.40From: 2018-12-31Exp: 2025-12-31→ Common Stock (62,500 underlying)
Exercise/Conversion
Option to Purchase Common Stock
2022-03-04−33,334→ 0 total
Exercise: $0.50From: 2022-03-04Exp: 2032-03-04→ Common Stock (33,334 underlying)
Exercise/Conversion
Common Stock
2024-11-15$0.40/sh+121,875$48,750→ 5,300,220 total
Exercise/Conversion
Common Stock
2024-11-15$0.40/sh+62,500$25,000→ 5,362,720 total
Exercise/Conversion
Common Stock
2024-11-15$0.50/sh+33,334$16,667→ 5,396,054 total

Documents

1 file

4
rdgdoc.xmlPrimary
S PITTMAN OPTION EXERCISE

Issuer

Nuo Therapeutics, Inc.

CIK 0001091596

Entity typeother

Related Parties

1

filerCIK 0001674752

Filing Metadata

Form type: 4
Filed: Nov 18, 7:00 PM ET
Accepted: Nov 19, 5:51 PM ET
Size: 13.3 KB

View on SEC.gov